Back to News
Market Impact: 0.3

Stocks making the biggest moves midday: Tesla, Ciena, Meta, Snowflake, Ultragenyx Pharmaceutical & more

Source: CNBC

+15
Corporate EarningsCorporate Guidance & OutlookCrypto & Digital AssetsCybersecurity & Data PrivacyHealthcare & BiotechTechnology & InnovationAnalyst Estimates
Stocks making the biggest moves midday: Tesla, Ciena, Meta, Snowflake, Ultragenyx Pharmaceutical & more

Market movers were broadly mixed: Tyson Foods fell ~7% after cutting fiscal 2026 adjusted operating income to $1.85B–$2.05B (from $2.1B–$2.3B) and lowering revenue growth to 1.5%–2.0%. Crypto-related stocks jumped as bitcoin rose >4% above $80,000, with Coinbase up ~10% and Strategy up ~13%, while Robinhood surged ~15% on Deutsche Bank’s prediction-market tailwind view. On the earnings side, Snowflake surged ~22% after Q2 results beat (EPS 62 cents vs 45 cents; revenue $1.55B vs $1.48B), but Ultragenyx plunged ~44% after Phase 3 Angelman syndrome results missed the primary endpoint and Moderna was downgraded to sell.

Analysis

This tape is rewarding names that can convert product momentum into visible near-term monetization and punishing any hint that margins are peaking. That favors software/data-platform exposure and ad/network effects over hardware-heavy beneficiaries of the AI cycle, where investors are becoming less tolerant of “good but not great” guidance. The second-order read-through is negative for legacy infrastructure suppliers and for semis priced for flawless AI margin expansion: if capex is still rising but returns are delayed, multiple expansion shifts from the hardware layer to the workload layer.

Crypto is still just high-beta macro. COIN, MSTR, and RIOT should continue to track BTC, but the trade only has durability if spot stays above the key round-number zone and rate-sensitive assets remain firm; a quick retrace in BTC would unwind this move faster than fundamentals can catch up. The prediction-market angle is more narrative than earnings power until actual contract volume and take rates prove out, so the broker beneficiary story is best treated as an option on future product adoption, not a core 2026 EPS upgrade.

The contrarian risk is that the market may be overpaying for “AI everywhere” while underestimating how much of the spend is still infrastructure digestion rather than incremental revenue. TSLA’s event can keep momentum alive for a session or two, but monetization is a 6-18 month question and the bar is now high. Falsifiers: BTC back below 75k, a post-event TSLA roadmap that lacks a credible commercialization timeline, or follow-through weakness in next-quarter orders/margins from the infrastructure names.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.15

Ticker Sentiment

ARLLF-0.15
AVGO-0.15
CIEN-0.15
COIN-0.15
CPB-0.15
CRM-0.15
DB-0.15
DDOG-0.15
DELL-0.15
HPE-0.15
META-0.15
MRNA-0.15
MSTR-0.15
NOW-0.15
NTAP-0.15
NTSK-0.15
RARE-0.15
REZNF-0.15
RIOT-0.15
SNOW-0.15
TSLA-0.15
TSN-0.15
VSCO-0.15

Key Decisions for Investors

  • Long SNOW / short NTAP for 1-3 months: express the view that software monetization is being rewarded while storage spend is getting more scrutinized; stop if SNOW retention or product revenue growth fails to hold up next report.
  • Long DELL / short HPE over the next 1-2 quarters: DELL has a cleaner AI-server conversion story and stronger earnings credibility, while HPE’s 2027 targets are too far out to drive near-term re-rating; exit if HPE shows material backlog acceleration.
  • Tactical long COIN or RIOT only if BTC holds above 80k for several sessions; use call spreads rather than outright common to define risk. Thesis breaks on a BTC close back below 75k.
  • Fade TSLA strength post-event with a 30-60 day put spread if the Cybercab presentation is mostly demo and lacks a concrete commercialization/regulatory path; cover immediately if the company gives a credible launch timeline.

More News

From AllMind Research

Browse all research